Milbank LLP advised Hohnhaus & Jansenberger on the transaction.
The Sino-French Fund II of Cathay Capital Private Equity is acquiring shares in medifa healthcare group, a portfolio company of the Hohnhaus & Jansenberger Group. With this investment, Cathay Capital will actively support the further growth of the company, in particular its expansion and acquisition objectives.
The Hohnhaus & Jansenberger Group, headquartered in Munich, is a medium-sized industrial group focusing on the areas of catering equipment, medical technology and stainless steel processing. With twelve locations in the DACH region and around 600 employees, the group generates an annual turnover of around €100 million.
The medifa healthcare Group is an owner-managed and globally active medical technology company with around 350 employees. The product and service portfolio covers the complete range of modular wall, door and ceiling systems, mobile operating tables and accessories, as well as examination chairs for gynaecology, urology and proctology. The group also owns one of the largest German OEM suppliers in the medical technology sector.
Cathay Capital Private Equity is an international private equity firm focused on cross-border investments and international expansion support for mid-sized companies in North America, China and Europe. Cathay, with offices in New York, Shanghai, Beijing, Paris, Munich, San Francisco and Tel Aviv, manages assets with a total volume of more than €2.8 billion and has completed over 100 buyouts and growth capital investments since its inception in 2007. The company invests primarily in companies in the area of consumer goods and services, healthcare, business services and technology.
Allen & Overy has advised Cathay Capital Private Equity on the transaction.
The Milbank team was composed by Martin Erhardt (lead, Corporate/M&A, Munich), Thomas Kleinheisterkamp (Tax, Munich), Alexander Rinne (Antitrust, Munich), Michael Pujol, Dominik Waldvogel, Lucas Kleinschmitt (all Corporate/M&A, Munich).
The Allen & Overy team was led by partner Dominik Stühler and counsel Dr Kai Terstiege (both Private Equity, Munich) and included partners Dr Heike Weber (Tax, Frankfurt) and Dr Jens Matthes (IP, Düsseldorf), counsels Dr René Galle (Antitrust, Hamburg) and Peter Wehner (Pensions, Frankfurt), senior associates Tobias Hoppe (Private Equity, Munich), Dr Sebastian Schulz (Employment, Frankfurt) and Eda Zhuleku (Life Science, Munich), as well as associates Elisabeth Pichler (Private Equity, Munich), Sven Bischoff (Tax, Frankfurt), Dr Till Goeckler (Antitrust, Hamburg) and Melissa Baudewig (IP, Düsseldorf).
Involved fees earner: Melissa Baudewig – Allen & Overy; Sven Bischoff – Allen & Overy; René Galle – Allen & Overy; Till Goeckler – Allen & Overy; Tobias Hoppe – Allen & Overy; Jens Matthes – Allen & Overy; Elisabeth Pichler – Allen & Overy; Sebastian Schulz – Allen & Overy; Dominik Stühler – Allen & Overy; Kai Terstiege – Allen & Overy; Heike Weber – Allen & Overy; Peter Wehner – Allen & Overy; Eda Zhuleku – Allen & Overy; Martin Erhardt – Milbank; Thomas Kleinheisterkamp – Milbank; Lucas Kleinschmitt – Milbank; Michael Pujol – Milbank; Alexander Rinne – Milbank; Dominik Waldvogel – Milbank;